Klaus Frueh, Ph.D., is a member of the board of directors and a co-founder of VIR. He is currently a professor and senior scientist at the Oregon Health & Science University (OHSU) and the Oregon National Primate Research Center (ONPRC). In 2000, he joined the OHSU Vaccine and Gene Therapy Institute as associate professor and the ONPRC as associate scientist, at the same time becoming director of the Microarray Shared Resource.
In 1994 he directed the antiviral pharmaceutical research program at the R.W. Johnson Pharmaceutical Research Institute. From 1991 to 1994 he was a postdoctoral scientist at the Scripps Research Institute in La Jolla, California. He received his Ph.D. from the University of Heidelberg in 1990.